Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
Unicycive Therapeutics, Inc. (UNCY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/31/2023 |
8-K
| Quarterly results |
07/26/2023 |
8-K
| Quarterly results |
05/23/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
05/16/2023 |
8-K
| Quarterly results |
03/31/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
03/30/2023 |
8-K
| Quarterly results |
03/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs:
|
"Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Voting Preferred Stock",
"Form of Specimen Stock Certificate for Series A-1 Preferred Stock",
"Form of Tranche A Warrant",
"Form of Tranche B Warrant",
"Form of Tranche C Warrant",
"Form of Securities Purchase Agreement, by and between Unicycive Therapeutics, Inc. and the purchasers named therein",
"Placement Agency Agreement, by and between Unicycive Therapeutics, Inc. and EF Hutton, division of Benchmark Investments, LLC",
"Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb" |
|
03/02/2023 |
8-K
| Other Events Interactive Data |
02/07/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
02/02/2023 |
8-K
| Quarterly results |
12/29/2022 |
8-K
| Quarterly results |
12/28/2022 |
8-K
| Investor presentation |
11/14/2022 |
8-K
| Quarterly results |
08/15/2022 |
8-K
| Quarterly results |
08/08/2022 |
8-K
| Quarterly results |
07/18/2022 |
8-K
| Quarterly results |
06/16/2022 |
8-K
| Quarterly results |
05/12/2022 |
8-K
| Quarterly results |
03/31/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
11/29/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/12/2021 |
8-K
| Quarterly results |
08/16/2021 |
8-K
| Quarterly results |
|
|